Though P-selectin and PSGL-1 antibodies have been shown to inhibit NETosis in mice [41], the disruption of leukocyte adhesion molecule binding capacity could decrease neutrophil recruitment in response to infection in cancer patients already suffering from an immunocompromised state. The gene discussed is SELP; the disease is cancer.